Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence settingThe diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugsThe GenoType® MTBDR sl test for resistance to second-line anti-tuberculosis drugsGenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugsRemoving the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to actionIncreased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputumUse of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic reviewWhat is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South AfricaCorrection: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South AfricaHigh frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisA Survey on Use of Rapid Tests and Tuberculosis Diagnostic Practices by Primary Health Care Providers in South Africa: Implications for the Development of New Point-of-Care TestsThe diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarceCorrelation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden settingImpact of the GeneXpert MTB/RIF Technology on Tuberculosis Control.EDCTP regional networks of excellence: initial merits for planned clinical trials in Africa.The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis.Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic reviewDifferent screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysisHIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria.Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developmentsSputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings.The immunology of tuberculosis: from bench to bedside.Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting.Making HIV testing work at the point of care in South Africa: a qualitative study of diagnostic practices.Feasibility and diagnostic utility of antigen-specific interferon-gamma responses for rapid immunodiagnosis of tuberculosis using induced sputum.Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study.Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppressionDiagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluidGlobal control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisComparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study.Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden.Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic populationComparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis.Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?Selection and application of ssDNA aptamers to detect active TB from sputum samples.
P50
Q21231998-ABCF2E00-5834-491E-A39F-D90E93E60A2BQ24193002-E6E9F5C0-DBD8-4EDA-B0A8-0A2726434F91Q24200646-EA8E1A16-B5A3-4A9A-B132-3FC9F79DCE31Q28068545-A0AEEAAA-9DB9-40D3-9BD4-A85600A6677CQ28070235-39A3E380-FF30-4490-AE22-EFDBDD782595Q28395969-7E38CD78-CC79-4219-BDAB-37F32710415AQ28484857-3926C270-688F-4BEF-A6E8-566CC6CAC43EQ28485194-8228F07A-550D-47C9-8617-A93CCAAEEAFDQ28487731-DC5DB387-C492-44A6-AD49-8D57B3CFB3F7Q28533564-F1CF9480-D3EA-407E-97B5-073A1221124DQ28546682-6CA4ED68-2CBC-4033-B73D-4ECB84B1231EQ28550535-FCB47143-2F86-4F08-BE87-AB0BDB41A47DQ28727351-A3EEB3EA-AB97-4756-938E-B32832E701CAQ28729742-32B554F8-164B-4F83-BD7B-5E4F290D705BQ30061839-33662E29-B572-454C-8399-3AFB810F86A8Q30393945-916C5281-62C4-4985-8C22-3EDEB9958CC6Q33294505-463E3E9D-0B20-4747-A198-8D5DB7397237Q33521202-11D533A7-F8E0-4B3E-977B-8D40ABC3674BQ33532816-9E6D9178-A8DA-42EC-BE0F-9216F9178C02Q33551482-341A542F-B687-4DCA-BE1A-C0B9335CE33CQ33676996-72FAB6D0-A30E-49E3-89F7-A0F01F61817CQ33754177-3B4D9C40-84E8-4F28-BDF0-B2882053FEF1Q33754205-AA56F57E-4EED-4458-962D-FB1391A1751EQ33777367-80A1F186-0878-4F36-BA96-612A16A5CABFQ33784672-618D8C80-810D-4385-9294-7ACDABDB8D8FQ33808392-96604D6C-2315-4F74-87E1-4BE55441E8A4Q33815988-D59500B3-2031-49C7-9FC4-181A61A4EE98Q33816191-7D859E1C-269C-4A7C-8DC3-D0E278234263Q33901601-A7DEE2B6-8E2E-4C7B-A1A1-1A23FD6E9CCCQ33924587-3DD15131-FD5F-443A-B618-46249FF84BA8Q33924814-966E9F66-D1FC-45B2-BF7B-EC4CDB33BEDBQ33924841-FEBB9FA8-36A2-4C0F-8260-332980D60FE6Q33926262-BE560977-CBA8-440D-97F2-D111374DD9C0Q33938728-AC20695F-1EF7-4E9C-BAB3-39E6FBD4B7D7Q33954547-81F3F5BA-A3AD-488D-B4AF-2E23391749B7Q34116991-9795E006-7541-4757-B4C0-12274D5B9A43Q34118528-9DEDB40A-0B00-4EDA-B975-F3481B0EF902Q34298219-DB973AB2-347F-474B-A32D-A0B064B97DA0Q34401214-57161117-8862-4071-9AB6-88A392FACD37Q34442333-B770237A-1658-4CFE-99DF-A334DD37411B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Keertan Dheda
@ast
Keertan Dheda
@en
Keertan Dheda
@es
Keertan Dheda
@nl
Keertan Dheda
@sl
type
label
Keertan Dheda
@ast
Keertan Dheda
@en
Keertan Dheda
@es
Keertan Dheda
@nl
Keertan Dheda
@sl
prefLabel
Keertan Dheda
@ast
Keertan Dheda
@en
Keertan Dheda
@es
Keertan Dheda
@nl
Keertan Dheda
@sl
P106
P19
P21
P214
22153893603102290470
P31
P569
1969-03-01T00:00:00Z
P7859
viaf-22153893603102290470